Patents by Inventor Joseph Leo Sullivan
Joseph Leo Sullivan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230271021Abstract: In embodiments a WCD system is worn and/or carried by an ambulatory patient. The WCD system analyzes an ECG signal of the patient, to determine whether or not the patient should be given an electric shock to restart their heart. If so, then the WCD system first gives a preliminary alarm to the patient, asking them to prove they are alive if they are. The WCD system further determines whether the ECG signal contains too much High Amplitude (H-A) noise, which can distort the analysis of the ECG signal. If too much H-A noise is detected for a long time, the WCD system may eventually alert the patient about their activity, so that the ECG noise may be abated. The WCD system may even pause the analysis of the ECG signal, so that there will be no preliminary alarms that could be false until the ECG noise is abated.Type: ApplicationFiled: May 5, 2023Publication date: August 31, 2023Applicant: West Affum Holdings DACInventors: Joseph Leo Sullivan, Jaeho Kim
-
Patent number: 11707632Abstract: In embodiments a WCD system is worn and/or carried by an ambulatory patient. The WCD system analyzes an ECG signal of the patient, to determine whether or not the patient should be given an electric shock to restart their heart. If so, then the WCD system first gives a preliminary alarm to the patient, asking them to prove they are alive if they are. The WCD system further determines whether the ECG signal contains too much High Amplitude (H-A) noise, which can distort the analysis of the ECG signal. If too much H-A noise is detected for a long time, the WCD system may eventually alert the patient about their activity, so that the ECG noise may be abated. The WCD system may even pause the analysis of the ECG signal, so that there will be no preliminary alarms that could be false until the ECG noise is abated.Type: GrantFiled: January 25, 2021Date of Patent: July 25, 2023Assignee: West Affum Holdings DACInventors: Joseph Leo Sullivan, Jaeho Kim
-
Patent number: 11464991Abstract: In some embodiments, a wearable medical device system includes a processor configured to determine whether a patient requires electrical therapy to be provided via a plurality of therapy electrodes, the electrical therapy comprising discharging at least a portion of a stored electrical charge from an energy storage module, and if so, cause a fluid deploying mechanism to deploy a portion of the stored fluid to an interface between at least two therapy electrodes and the patient's skin prior to providing the electrical therapy, the deployed portion of fluid adapted to decrease the impedance measured by an impedance measurement circuit, and cause the fluid deploying mechanism to deploy an additional portion of fluid in response to the impedance measured by the impedance measurement circuit increasing above a threshold during the electrical therapy.Type: GrantFiled: December 17, 2019Date of Patent: October 11, 2022Assignee: West Affum Holdings Corp.Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, Jr., David Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas
-
Publication number: 20210361956Abstract: In embodiments a wearable cardioverter defibrillator (WCD) system is worn by an ambulatory patient. The WCD system analyzes an ECG signal of the patient, to determine whether or not the patient should be given an electric shock to restart their heart. If the WCD system determines that such a shock should be given, then it also determines whether or not a High Frequency (H-F) noise criterion is met by the ECG signal. If that H-F noise criterion is not met, the patient can be shocked. If, however, that H-F noise criterion is met, then the WCD system can confirm before shocking, by sensing another portion of the ECG signal, analyzing again, and so on. Thanks to the confirmation before shocking, the possibility is diminished that the ECG signal will indicate that a shock is needed falsely, due to H-F noise. This can further reduce false patient alarms, and so on.Type: ApplicationFiled: August 4, 2021Publication date: November 25, 2021Applicant: West Affum Holdings Corp.Inventors: Joseph Leo Sullivan, Jaeho Kim
-
Patent number: 11103717Abstract: In embodiments a wearable cardioverter defibrillator (WCD) system is worn by an ambulatory patient. The WCD system analyzes an ECG signal of the patient, to determine whether or not the patient should be given an electric shock to restart their heart. If the WCD system determines that such a shock should be given, then it also determines whether or not a High Frequency (H-F) noise criterion is met by the ECG signal. If that H-F noise criterion is not met, the patient can be shocked. If, however, that H-F noise criterion is met, then the WCD system can confirm before shocking, by sensing another portion of the ECG signal, analyzing again, and so on. Thanks to the confirmation before shocking, the possibility is diminished that the ECG signal will indicate that a shock is needed falsely, due to H-F noise. This can further reduce false patient alarms, and so on.Type: GrantFiled: July 17, 2018Date of Patent: August 31, 2021Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Joseph Leo Sullivan, Jaeho Kim
-
Patent number: 11026578Abstract: Patient electrodes, patient monitors, defibrillators, wearable defibrillators, software and methods may warn when an electrode stops being fully attached to the patient's skin. A patient electrode includes a pad for attaching to the skin of a patient, a lead coupled to the pad, and a contact detector that can change state, when the pad does not contact fully the skin of the patient. When the detector changes state, an output device may emit an alert, for notifying a rescuer or even the patient.Type: GrantFiled: June 8, 2018Date of Patent: June 8, 2021Assignee: West Affum Holdings Corp.Inventors: Blaine Krusor, Isabelle Banville, Joseph Leo Sullivan, David Peter Finch, Daniel Ralph Piha, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Carmen Ann Chacon, Gregory T. Kavounas
-
Publication number: 20210146149Abstract: In embodiments a WCD system is worn and/or carried by an ambulatory patient. The WCD system analyzes an ECG signal of the patient, to determine whether or not the patient should be given an electric shock to restart their heart. If so, then the WCD system first gives a preliminary alarm to the patient, asking them to prove they are alive if they are. The WCD system further determines whether the ECG signal contains too much High Amplitude (H-A) noise, which can distort the analysis of the ECG signal. If too much H-A noise is detected for a long time, the WCD system may eventually alert the patient about their activity, so that the ECG noise may be abated. The WCD system may even pause the analysis of the ECG signal, so that there will be no preliminary alarms that could be false until the ECG noise is abated.Type: ApplicationFiled: January 25, 2021Publication date: May 20, 2021Applicant: West Affum Holdings Corp.Inventors: Joseph Leo Sullivan, Jaeho Kim
-
Patent number: 10918879Abstract: In embodiments a WCD system is worn and/or carried by an ambulatory patient. The WCD system analyzes an ECG signal of the patient, to determine whether or not the patient should be given an electric shock to restart their heart. If so, then the WCD system first gives a preliminary alarm to the patient, asking them to prove they are alive if they are. The WCD system further determines whether the ECG signal contains too much High Amplitude (H-A) noise, which can distort the analysis of the ECG signal. If too much H-A noise is detected for a long time, the WCD system may eventually alert the patient about their activity, so that the ECG noise may be abated. The WCD system may even pause the analysis of the ECG signal, so that there will be no preliminary alarms that could be false until the ECG noise is abated.Type: GrantFiled: July 17, 2018Date of Patent: February 16, 2021Assignee: West Affum Holdings Corp.Inventors: Joseph Leo Sullivan, Jaeho Kim
-
Publication number: 20200121938Abstract: In some embodiments, a wearable medical device system includes a processor configured to determine whether a patient requires electrical therapy to be provided via a plurality of therapy electrodes, the electrical therapy comprising discharging at least a portion of a stored electrical charge from an energy storage module, and if so, cause a fluid deploying mechanism to deploy a portion of the stored fluid to an interface between at least two therapy electrodes and the patient's skin prior to providing the electrical therapy, the deployed portion of fluid adapted to decrease the impedance measured by an impedance measurement circuit, and cause the fluid deploying mechanism to deploy an additional portion of fluid in response to the impedance measured by the impedance measurement circuit increasing above a threshold during the electrical therapy.Type: ApplicationFiled: December 17, 2019Publication date: April 23, 2020Applicant: West Affum Holdings Corp.Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, JR., Daniel Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas
-
Patent number: 10507331Abstract: In embodiments, a wearable cardiac defibrillator system includes an energy storage module configured to store a charge. Two electrodes can be configured to be applied to respective locations of a patient. One or more reservoirs can store one or more conductive fluids. Respective fluid deploying mechanisms can be configured to cause the fluids to be released from one or more of the reservoirs, which decreases the impedance at the patient location, and decreases discomfort for the patient. In some embodiments an impedance is sensed between the two electrodes, and the stored charge is delivered when the sensed impedance meets a discharge condition. In some embodiments, different fluids are released for different patient treatments. In some embodiments, fluid release is controlled to be in at least two doses, with an intervening pause.Type: GrantFiled: January 9, 2018Date of Patent: December 17, 2019Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, Jr., Daniel Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas
-
Publication number: 20190030352Abstract: In embodiments a WCD system is worn and/or carried by an ambulatory patient. The WCD system analyzes an ECG signal of the patient, to determine whether or not the patient should be given an electric shock to restart their heart. If so, then the WCD system first gives a preliminary alarm to the patient, asking them to prove they are alive if they are. The WCD system further determines whether the ECG signal contains too much High Amplitude (H-A) noise, which can distort the analysis of the ECG signal. If too much H-A noise is detected for a long time, the WCD system may eventually alert the patient about their activity, so that the ECG noise may be abated. The WCD system may even pause the analysis of the ECG signal, so that there will be no preliminary alarms that could be false until the ECG noise is abated.Type: ApplicationFiled: July 17, 2018Publication date: January 31, 2019Inventors: Joseph Leo Sullivan, Jaeho Kim
-
Publication number: 20190030351Abstract: In embodiments a wearable cardioverter defibrillator (WCD) system is worn by an ambulatory patient. The WCD system analyzes an ECG signal of the patient, to determine whether or not the patient should be given an electric shock to restart their heart. If the WCD system determines that such a shock should be given, then it also determines whether or not a High Frequency (H-F) noise criterion is met by the ECG signal. If that H-F noise criterion is not met, the patient can be shocked. If, however, that H-F noise criterion is met, then the WCD system can confirm before shocking, by sensing another portion of the ECG signal, analyzing again, and so on. Thanks to the confirmation before shocking, the possibility is diminished that the ECG signal will indicate that a shock is needed falsely, due to H-F noise. This can further reduce false patient alarms, and so on.Type: ApplicationFiled: July 17, 2018Publication date: January 31, 2019Inventors: Joseph Leo Sullivan, Jaeho Kim
-
Publication number: 20180289275Abstract: Patient electrodes, patient monitors, defibrillators, wearable defibrillators, software and methods may warn when an electrode stops being fully attached to the patient's skin. A patient electrode includes a pad for attaching to the skin of a patient, a lead coupled to the pad, and a contact detector that can change state, when the pad does not contact fully the skin of the patient. When the detector changes state, an output device may emit an alert, for notifying a rescuer or even the patient.Type: ApplicationFiled: June 8, 2018Publication date: October 11, 2018Inventors: Blaine Krusor, Isabelle Banville, Joseph Leo Sullivan, David Peter Finch, Daniel Ralph Piha, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Carmen Ann Chacon, Gregory T. Kavounas
-
Patent number: 10022062Abstract: Patient electrodes, patient monitors, defibrillators, wearable defibrillators, software and methods may warn when an electrode stops being fully attached to the patient's skin. A patient electrode includes a pad for attaching to the skin of a patient, a lead coupled to the pad, and a contact detector that can change state, when the pad does not contact fully the skin of the patient. When the detector changes state, an output device may emit an alert, for notifying a rescuer or even the patient.Type: GrantFiled: February 14, 2017Date of Patent: July 17, 2018Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Blaine Krusor, Isabelle Banville, Joseph Leo Sullivan, David Peter Finch, Daniel Ralph Piha, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Carmen Ann Chacon, Gregory T. Kavounas
-
Patent number: 9987496Abstract: A wearable medical device includes a garment and a medical device. The medical device has a functionality that can transition between an operative state and an inoperative state. When the functionality is in the inoperative state, a protrusion extends so as to poke the patient, as an indication that steps need to be taken to make the device ready for use.Type: GrantFiled: August 8, 2017Date of Patent: June 5, 2018Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Joseph Leo Sullivan, Isabelle Banville, Blaine Krusor, Daniel Ralph Piha, Laura Marie Gustavson, David Peter Finch, Kenneth Frederick Cowan, Richard C. Nova
-
Publication number: 20180147414Abstract: In embodiments, a wearable cardiac defibrillator system includes an energy storage module configured to store a charge. Two electrodes can be configured to be applied to respective locations of a patient. One or more reservoirs can store one or more conductive fluids. Respective fluid deploying mechanisms can be configured to cause the fluids to be released from one or more of the reservoirs, which decreases the impedance at the patient location, and decreases discomfort for the patient. In some embodiments an impedance is sensed between the two electrodes, and the stored charge is delivered when the sensed impedance meets a discharge condition. In some embodiments, different fluids are released for different patient treatments. In some embodiments, fluid release is controlled to be in at least two doses, with an intervening pause.Type: ApplicationFiled: January 9, 2018Publication date: May 31, 2018Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, JR., Daniel Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas
-
Patent number: 9895548Abstract: In embodiments, a wearable cardiac defibrillator system includes an energy storage module configured to store a charge. Two electrodes can be configured to be applied to respective locations of a patient. One or more reservoirs can store one or more conductive fluids. Respective fluid deploying mechanisms can be configured to cause the fluids to be released from one or more of the reservoirs, which decreases the impedance at the patient location, and decreases discomfort for the patient. In some embodiments an impedance is sensed between the two electrodes, and the stored charge is delivered when the sensed impedance meets a discharge condition. In some embodiments, different fluids are released for different patient treatments. In some embodiments, fluid release is controlled to be in at least two doses, with an intervening pause.Type: GrantFiled: June 6, 2017Date of Patent: February 20, 2018Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, Jr., Daniel Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas
-
Publication number: 20170368361Abstract: A wearable medical device includes a garment and a medical device. The medical device has a functionality that can transition between an operative state and an inoperative state. When the functionality is in the inoperative state, a protrusion extends so as to poke the patient, as an indication that steps need to be taken to make the device ready for use.Type: ApplicationFiled: August 8, 2017Publication date: December 28, 2017Inventors: Joseph Leo Sullivan, Isabelle Banville, Blaine Krusor, Daniel Ralph Piha, Laura Marie Gustavson, David Peter Finch, Kenneth Frederick Cowan, Richard C. Nova
-
Patent number: 9795782Abstract: RFID-based sensors, RFID readers and software sense a changed condition. In one embodiment, an RFID-based sensor includes a base that may be placed at a location where a condition may change. The sensor includes an RFID tag that is coupled to the base. The sensor also includes a detector that can be electrically coupled to the RFID tag. If the condition changes, an electrical property of the detector also changes, impacting an operation of the RFID tag. The impacted operation can be detected by an RFID reader/interrogator so as to provide a notification. An advantage over the prior art is that the condition change can be sensed wirelessly over a domain that can be laborious or hazardous to access otherwise. Moreover, RFID based sensors can be made by modifying common RFID tags.Type: GrantFiled: March 14, 2016Date of Patent: October 24, 2017Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Blaine Krusor, Isabelle Banville, Joseph Leo Sullivan, David Peter Finch, Daniel Ralph Piha, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Carmen Ann Chacon, Gregory T. Kavounas
-
Publication number: 20170266456Abstract: In embodiments, a wearable cardiac defibrillator system includes an energy storage module configured to store a charge. Two electrodes can be configured to be applied to respective locations of a patient. One or more reservoirs can store one or more conductive fluids. Respective fluid deploying mechanisms can be configured to cause the fluids to be released from one or more of the reservoirs, which decreases the impedance at the patient location, and decreases discomfort for the patient. In some embodiments an impedance is sensed between the two electrodes, and the stored charge is delivered when the sensed impedance meets a discharge condition. In some embodiments, different fluids are released for different patient treatments. In some embodiments, fluid release is controlled to be in at least two doses, with an intervening pause.Type: ApplicationFiled: June 6, 2017Publication date: September 21, 2017Inventors: Daniel Ralph Piha, Joseph Leo Sullivan, Phillip Dewey Foshee, JR., Daniel Peter Finch, Isabelle Banville, Laura Marie Gustavson, Kenneth Frederick Cowan, Richard C. Nova, Robert Reuben Buchanan, Krystyna Szul, Gregory T. Kavounas